Haemonetics (HAE)

Haemonetics (HAE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• HAE last traded at $121.00, 1.13% on the day.
• Haemonetics: market cap $5.44B, P/E 58.7, revenue $1.35B over the last four quarters, next earnings 2026-11-05.
• Over the past year HAE returned 142.05%; year to date 50.97%.

Updated 2026-11-02 17:49 UTC